CYTK Stock Analysis: Buy, Sell, or Hold?
CYTK - Cytokinetics Inc.
$62.50
-0.98 (-1.54%)
▼
5d:
+1.3%
30d:
-0.21%
90d:
-2.82%
BUY
HIGH Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 05, 2026
Smart Money Accumulation
CYTK is down 3.4% this week, but smart money is accumulating calls. Top strike: $70 2026-05-15 with 14,010 OI. Call ratio: 73% View Scanner →
Strength: 4.0/10
Get Alerted When CYTK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CYTK shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: CYTK shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: CYTK is currently trading at $62.50, which is considered fair relative to its 30-day fair value range of $60.47 to $65.87.
Technical Outlook: Technically, CYTK is in a strong uptrend. Immediate support is located at $59.03, while resistance sits at $64.74.
Market Sentiment: CYTK has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $91.89 (+47.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CYTK is in a strong uptrend. Immediate support is located at $59.03, while resistance sits at $64.74.
Market Sentiment: CYTK has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $91.89 (+47.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$60.47 -
$65.87
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 47.0% below Wall St target ($91.89)
Fair Price Analysis
30-Day Fair Range
$60.47 -
$65.87
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$59.03
Resistance Level
$64.74
Current Trend
Strong Uptrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.67
Wall Street Target
$91.89
(+47.0%)
Revenue Growth (YoY)
4.9%
Share & Embed Analysis
Last updated: March 30, 2026 8:56 AM ET
Data refreshes hourly during market hours. Next update: 9:56 AM
Data refreshes hourly during market hours. Next update: 9:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CYTK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Andrew Callos
SELL
1930 shares
2026-03-18
Andrew Callos
SELL
8542 shares
2026-03-17
Fady Ibraham Malik
SELL
12033 shares
2026-03-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$54 | 54 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 61 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 63 BUY |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
15 analysts |
$669 | 65 BUY |
Advanced CYTK Option Strategies
Professional options setups generated by AI based on today's CYTK price and gamma walls.
